Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers.

Source:http://linkedlifedata.com/resource/pubmed/id/12445025

Download in:

View as

General Info

PMID
12445025